News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: European Lithium Limited (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on European Lithium Limited to Buy with a target price of €0.14. The company has made significant progress with its lithium projects and financing strategies in 2024 -
COMMUNIQUÉ DE PRESSE
Knorr-Bremse divests R.H. Sheppard Co., Inc. in North America and writes down remaining purchase price receivable
Knorr-Bremse divests R.H. Sheppard Co., Inc. in North America and writes down remaining purchase price receivable to optimize portfolio and focus on core competencies -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Knorr-Bremse Divests R.H. Sheppard Co., Inc. in North America and Adjusts Fair Value of Remaining Purchase Price Receivable
Knorr-Bremse divests R.H. Sheppard Co., Inc. in North America and adjusts fair value of purchase price receivable. Company expects stable dividend for 2024 amidst portfolio optimization -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Talanx Aktiengesellschaft: Strategic partnership between Talanx AG and Meiji Yasuda Life Insurance Company will expire on 31 December 2025
Talanx AG's strategic partnership with Meiji Yasuda Life Insurance Company set to expire on December 31, 2025. Talanx aims to acquire minority shares in Warta S.A. and TU Europa S.A -
-
COMMUNIQUÉ DE PRESSE
Silver Spruce and Partner Colibri Resource Complete 2024 Drilling Program on Four Polymetallic Targets at Diamante Au-Ag Project, Sonora, Mexico
Silver Spruce Resources Inc. and Colibri Resource Corp. announce completion of core drilling operations at Diamante project, revealing high-grade mineralization. Future exploration prospects look promising -
COMMUNIQUÉ DE PRESSE
Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders
